Gestión Bout III Meridion Ptr Glb FI
Portfolio
Holdings
Symbol | Name | Country | Sector | Industry | Most recent quarter | % of Total Shares | % of Total Assets | Shares | Book Value | Market Price Value | Fundamental Score | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALVR.NASDAQ | Allovir Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.062 | 1.632 | 71.2k | $74.8k | $32.3k |
| |||||||||||||
ENZ.NYSE | Enzo Biochem Inc | USA | Healthcare | Diagnostics & Research | 2024-10-31 | 0.086 | 2.038 | 45.1k | $41.1k | $33.2k |
|
Trades
Adds
Report date: 2024-09-30
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
ENZ.NYSE | 11k | 32.3 | 12.3k | 1-1 | $0.74 | -26.0% |
Reduces
Report date: 2024-11-30
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
ALVR.NASDAQ | -800.00 | -1.1 | -603.31 | 1-1 | $0.45 | -11.0% |
Comments
How you think about this?